Fact CheckerSign in

NCT04544917Completed

SmartManage Stress Management for HIV+ Cancer Survivors

Development of an eHealth-based Cognitive Behavioral Stress and Self-Management Intervention to Reduce Symptom Burden in HIV+ Gay and Bisexual Men Who Have Sex With Men (MSM) Treated for Non-Metastatic Cancer

Source: ClinicalTrials.gov · Last updated 13 Aug 2025

Brief summary (registry, in English)

The purpose of this study is to design and refine a web-based platform developed for managing symptom burden in men who have sex who are HIV+ cancer survivors.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
3 Sept 2020
Start date
15 Feb 2021
Primary completion date
3 Sept 2024
Lead sponsor
University of Miami
Diseases
HIV
NCT number
NCT04544917

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 15 Feb 2021 to the primary completion date, 3 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have had one of the following exclusionary cancer types: Non-melanoma skin cancer, brain cancer, eye cancer, history of some form of pediatric cancer (if that is participant's only cancer diagnosis)
  • History of advanced (metastatic) cancer of any type
  • Inpatient treatment for severe mental illness in the past 12 months and/or suicidality of moderate or greater risk
  • Have any other medical condition resulting in predicted live expectancy of less than 12 months

Other

  • Appears actively intoxicated or otherwise unable to provide full informed consent

Who the study is looking for

  • Age: 18 years or older
  • Fluent in English
  • Have evidence of at least one form of non-metastatic solid tumor cancer or blood cancer
  • Be at least 30 days post active primary cancer treatment
  • Self identify as a sexual minority cisgender man
  • Self-report having been diagnosed with HIV
  • Have reliable access to a computer/device with internet accessibility

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Miami
Coordinator of this site? Confirm its status
MiamiUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.